Institutional Ownership Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC). We have compiled data on the 157 institutions that hold shares in the stock, with a total of 105 Million shares, which have been reported (via 13F filing form) to have a value of $1.37 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2025 Q3 2025 |
1,097,497
shares
|
$14.4 Million
0.28% of portfolio
|
Q3 2025
Reduced 14.15%
|
|
|
Invus Financial Advisors, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
1,007,575
shares
|
$13.2 Million
7.98% of portfolio
|
Q4 2020
Reduced -0.0%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2025 Q3 2025 |
1,007,575
shares
|
$13.2 Million
0.47% of portfolio
|
Q3 2024
New holding
|
|
|
Euclidean Capital LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
989,410
shares
|
$13 Million
5.03% of portfolio
|
Q3 2023
Added 32.35%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
951,507
shares
|
$12.5 Million
0.21% of portfolio
|
Q3 2025
Added 0.01%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
904,812
shares
|
$11.8 Million
0.0% of portfolio
|
Q3 2025
Added 84.79%
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2025 Q3 2025 |
900,000
shares
|
$11.8 Million
0.82% of portfolio
|
Q3 2025
Reduced 28.0%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
888,535
shares
|
$11.6 Million
0.0% of portfolio
|
Q3 2025
Added 121.61%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
793,871
shares
|
$10.4 Million
0.0% of portfolio
|
Q3 2025
Added 11.05%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
745,528
shares
|
$9.76 Million
0.0% of portfolio
|
Q3 2025
Added 88.84%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
603,207
shares
|
$7.9 Million
0.0% of portfolio
|
Q3 2025
Added 57.75%
|
|
|
Memorial Sloan Kettering Cancer Center
New York, NY |
Nov 14, 2023 Q3 2023 |
602,272
shares
|
$7.88 Million
14.83% of portfolio
|
Q4 2020
New holding
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
468,610
shares
|
$6.13 Million
0.03% of portfolio
|
Q3 2025
New holding
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
447,366
shares
|
$5.86 Million
0.01% of portfolio
|
Q3 2025
Added 22.43%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Nov 14, 2025 Q3 2025 |
431,693
shares
|
$5.65 Million
1.35% of portfolio
|
Q3 2025
Added 9.37%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
339,236
shares
|
$4.44 Million
0.0% of portfolio
|
Q3 2025
Added 242.64%
|
|
|
Sectoral Asset Management Inc
Montreal, A8 |
Nov 14, 2025 Q3 2025 |
328,655
shares
|
$4.3 Million
3.78% of portfolio
|
Q3 2025
Added 41.98%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
246,534
shares
|
$3.23 Million
0.02% of portfolio
|
Q3 2025
Added 0.89%
|
|
|
Nicholas Investment Partners, LP
Rancho Santa Fe, CA |
Nov 14, 2025 Q3 2025 |
220,735
shares
|
$2.89 Million
0.25% of portfolio
|
Q3 2025
Added 197.32%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
184,091
shares
|
$2.41 Million
0.0% of portfolio
|
Q3 2025
Added 29.02%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
171,925
shares
|
$2.25 Million
0.0% of portfolio
|
Q3 2025
Added 0.29%
|
|
|
Resolute Capital Asset Partners LLC
Denver, CO |
Nov 14, 2025 Q3 2025 |
167,515
shares
|
$2.19 Million
1.21% of portfolio
|
Q3 2025
Reduced 26.37%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
167,502
shares
|
$2.19 Million
0.0% of portfolio
|
Q3 2024
Added 0.79%
|
|
|
Stem Point Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
166,461
shares
|
$2.18 Million
0.4% of portfolio
|
Q3 2025
Reduced 17.09%
|
|
|
Td Asset Management Inc
|
Nov 10, 2025 Q3 2025 |
151,700
shares
|
$1.99 Million
0.0% of portfolio
|
Q3 2025
Reduced 14.63%
|
|